A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: A multi-cohort study

Accurate microsatellite instability (MSI) testing is essential for identifying gastric cancer (GC) patients eligible for immunotherapy. We aimed to develop and validate a CT-based radiomics signature to predict MSI and immunotherapy outcomes in GC.